CytomX to Receive $5 Million Milestone Payment From Regeneron Collaboration
CytomX Therapeutics achieved a preclinical milestone in its collaboration with Regeneron, triggering a $5 million payment.
CytomX Therapeutics achieved a preclinical milestone in its collaboration with Regeneron, triggering a $5 million payment.